glycopeptide antibiotic


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.

glycopeptide antibiotic

class of antibiotic that inhibits cell wall synthesis.
See also: vancomycin.

glycopeptide antibiotic

Any antibiotic composed of a short amino acid chain linked to a carbohydrate. Vancomycin and teicoplanin are glycopeptide antibiotics.
See also: antibiotic
References in periodicals archive ?
The failure of glycopeptide antibiotics led to the creation of a new class of drug, the streptogramins, a combination of quinipristin and dalfopristin.
Glycopeptide antibiotics: From conventional molecules to new derivatives.
The relevant markets in which overlaps occurred were found to be for vitamin B12 in France, positive inotropic agents in the United Kingdom and Belgium, cerebral and peripheral vasotherapeutics in Ireland, topical varicose therapy in Italy, macrolides and similar types in France, glycopeptide antibiotics also in France, specific anti-rheumatics in Portugal, muscle relaxants also in Portugal, hypnotics and sedatives in Greece, Ireland, Luxembourg and Sweden, heparins and heparinoids in Germany, Austria, Belgium, Spain, Finland, France, Italy, Luxembourg, the Netherlands, Portugal and the United Kingdom, and treatment of colorectal cancer in France, Germany, Italy, the Netherlands, Spain, Sweden and the United Kingdom.
Structure, biochemistry, and mechanism of action of glycopeptide antibiotics. Enr J Clin Microbiol Infcct Dis.
Among all enterococci, resistance to glycopeptide antibiotics was found in 12 (12.12%) strains.
For this reason, glycopeptide antibiotics (vancomycin and teicoplanin) have now become the foundation of chemotherapy in CNS infections worldwide.
Spread of methicillin-resistant Staphylococcus aureus belonging to the Brazilian epidemic clone in a general hospital and emergence of heterogeneous resistance to glycopeptide antibiotics among these isolates.
Glycopeptide antibiotics are bactericidal agents which interfere with bacterial cell wall synthesis.
Three cases of infection by Staphylococcus aureus with reduced susceptibility to the glycopeptide antibiotics vancomycin and teicoplanin (glycopeptide intermediate S.